Breast cancer screening AI app OK'd by watchdog
An AI application that aids early stage breast cancer screening has been approved by the US Food and Drug Administration for commercialization, software developer MedCognetics announced this week.
MedCognetics, based in Texas, has built a cloud-based software-as-a-service system for radiologists that analyzes mammograms. The systems runs QmTRIAGE, the company's breast cancer screening tool, which just received 510 clearance from the FDA. QmTRIAGE is powered by computer vision algorithms trained to estimate the density of breast tissue to detect things like cysts or tumors associated with cancer in mammography scans. Radiologists have to scrutinize these scans carefully to determine whether a patient requires a follow-up biopsy to test for breast cancer. MedCognetics believes its tool will aid radiologists by highlighting breast tissue that needs further examination.
"It will help with cost and time savings, reducing the amount of time a radiologist needs to review a case by 30 to 50 percent," MedCognetics' CEO, Debasish 'Ron' Nag, claimed in a statement to. This is an important factor, given that demand for radiologists vastly outpaces supply, and burnout in the profession is rampant.
"The vast majority of early stage cancers do not present with any clinical signs – they are detected on a screening mammogram before the woman has any symptoms. The only cure to breast cancer today is early detection. To enable that you need to see beyond the naked eye, and this is what MedCognetics does," he added.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mum dies after being given cancer diagnosis same day she gave birth to daughterKaryn Love, 39, only had 19 short months with her daughter before she died from breast cancer this week.
Read more »
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A - Nature CommunicationsPhosphoproteomics is a promising tool for identifying biomarkers of treatment response in cancer. Here, the authors analyse proteomics profiling of HER2-negative female breast cancer patients and identify potential predictors of paclitaxel response.
Read more »
Research links gene variants to medication-induced fatal brain infectionNew research has confirmed a strong link between four genetic mutations and progressive multifocal leukoencephalopathy (PML), a rare but often fatal brain infection that can be triggered by dozens of FDA-approved drugs.
Read more »
Huge fire at Russian power plant fuels rumours that saboteurs are getting braverAnother suspicious fire has started in Russia as the country struggles amid the Ukrainian war. The military-linked Zvezda engineering plant in St Petersburg caught ablaze – further fuelling rumours that Russia is being hit by sabotage attacks.
Read more »
How US scientists moved one step closer to dream of fusion power\n\t\t\tJournalists in 50+ countries follow the constant flow of money made and lost in oil & gas while\n\t\t\ttracking emerging trends and opportunities in the future of energy. Don’t miss our exclusive\n\t\t\tnewsletter, Energy Source.\n\t\t
Read more »
Supply Chain Woes Slow U.S. Solar Boom | OilPrice.com“America’s clean energy economy hindered by its own trade actions,” SEIA president and CEO Abigail Ross Hopper said in a statement.
Read more »